Mike Hollan

home / authors / mike-hollan

Mike Hollan is an editor for Pharmaceutical Executive and can be reached at mhollan@mjhlifesciences.com.

Articles

Q&A With Kathi Enderes, Senior Vice President at Josh Bersin Company

Q&A With Kathi Enderes, Senior Vice President at Josh Bersin Company

March 29th 2023

Healthcare companies are basing solutions for a potential nursing shortage on the tech industry.

Word news written with white solid letters By daboost

MedExecWomen’s Live Boston Conference Returns this Year

March 28th 2023

The event is scheduled for Tuesday, May 16, at the Le Meridien Hotel in Cambridge.

Craig Gravina

Q&A With Craig Gravine, CTO at ObvioHealth

March 22nd 2023

Clinical trials for digital therapeutics have unique problems when it comes to collecting data, especially regarding adherence and efficacy. Gravine speaks with MDT about a new API from ObvioHealth that works to solve these issues.

Lindsey Harbison

Q&A With Lindsey Harbison, Assistant Executive Director at 80th Street Residence, NYC

March 21st 2023

MDT spoke with Harbison about the technology used at the 80th Street Residence in NYC that helps monitor the symptoms of patients with cognitive issues.

CDMOs Show Strong Growth in 2023 US MedTech Contract Manufacturing Report

March 8th 2023

Alira Health and MassMEDIC collaborated on the report.

ObvioHealth Announces API For More Accurate Adherence and Efficacy Data Collection in Clinical Trials

ObvioHealth Announces API For More Accurate Adherence and Efficacy Data Collection in Clinical Trials

March 7th 2023

The new API aims to collect more accurate information by utilizing techniques designed to avoid altering patient behavior.

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

November 22nd 2022

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences companies, payers, and others in harnessing a healthcare future that will be increasingly dominated by holistic treatment and delivery.